208 related articles for article (PubMed ID: 30949839)
1. Which treatment is best for patients with AJCC stage IV bladder cancer?
Mao W; Ma B; Huang X; Gu S; Luo M; Fan J; Geng J
Int Urol Nephrol; 2019 Jul; 51(7):1145-1156. PubMed ID: 30949839
[TBL] [Abstract][Full Text] [Related]
2. Contemporary use and survival after perioperative systemic chemotherapy in patients with locally advanced non-metastatic urothelial carcinoma of the bladder treated with radical cystectomy.
Mazzone E; Nazzani S; Knipper S; Tian Z; Preisser F; Gallina A; Soulières D; Tilki D; Montorsi F; Shariat SF; Saad F; Briganti A; Wisnivesky J; Karakiewicz PI
Eur J Surg Oncol; 2019 Jul; 45(7):1253-1259. PubMed ID: 30755341
[TBL] [Abstract][Full Text] [Related]
3. Treatment Patterns and Survival Outcomes for Patients with Small Cell Carcinoma of the Bladder.
Fischer-Valuck BW; Rao YJ; Henke LE; Rudra S; Hui C; Baumann BC; Gay HA; Michalski JM
Eur Urol Focus; 2018 Dec; 4(6):900-906. PubMed ID: 28919521
[TBL] [Abstract][Full Text] [Related]
4. Contemporary use trends and survival outcomes in patients undergoing radical cystectomy or bladder-preservation therapy for muscle-invasive bladder cancer.
Cahn DB; Handorf EA; Ghiraldi EM; Ristau BT; Geynisman DM; Churilla TM; Horwitz EM; Sobczak ML; Chen DYT; Viterbo R; Greenberg RE; Kutikov A; Uzzo RG; Smaldone MC
Cancer; 2017 Nov; 123(22):4337-4345. PubMed ID: 28743162
[TBL] [Abstract][Full Text] [Related]
5. Partial Cystectomy With Pelvic Lymph Node Dissection for Patients With Nonmetastatic Stage pT2-T3 Urothelial Carcinoma of Urinary Bladder: Temporal Trends and Survival Outcomes.
Mistretta FA; Cyr SJ; Luzzago S; Mazzone E; Knipper S; Palumbo C; Tian Z; Nazzani S; Saad F; Montanari E; Tilki D; Briganti A; Shariat SF; de Cobelli O; Karakiewicz PI
Clin Genitourin Cancer; 2020 Apr; 18(2):129-137.e3. PubMed ID: 32001182
[TBL] [Abstract][Full Text] [Related]
6. Superior efficacy of neoadjuvant chemotherapy and radical cystectomy in cT3-4aN0M0 compared to cT2N0M0 bladder cancer.
Hermans TJN; Voskuilen CS; Deelen M; Mertens LS; Horenblas S; Meijer RP; Boormans JL; Aben KK; van der Heijden MS; Pos FJ; de Wit R; Beerepoot LV; Verhoeven RHA; van Rhijn BWG
Int J Cancer; 2019 Mar; 144(6):1453-1459. PubMed ID: 30155893
[TBL] [Abstract][Full Text] [Related]
7. Differential effect on survival of pelvic lymph node dissection at radical cystectomy for muscle invasive bladder cancer.
Larcher A; Sun M; Schiffmann J; Tian Z; Shariat SF; McCormack M; Saad F; Fossati N; Abdollah F; Briganti A; Buffi N; Graefen M; Guazzoni G; Montorsi F; Karakiewicz PI
Eur J Surg Oncol; 2015 Mar; 41(3):353-60. PubMed ID: 25477269
[TBL] [Abstract][Full Text] [Related]
8. Increasing Rates of Perioperative Chemotherapy are Associated With Improved Survival in Men With Urothelial Bladder Cancer With Prostatic Stromal Invasion.
Rosiello G; Knipper S; Palumbo C; Pecoraro A; Luzzago S; Deuker M; Tian Z; Gandaglia G; Gallina A; Montorsi F; Shariat SF; Saad F; Briganti A; Karakiewicz PI
Clin Genitourin Cancer; 2020 Feb; 18(1):35-44.e1. PubMed ID: 31711842
[TBL] [Abstract][Full Text] [Related]
9. Comparative effectiveness of radical cystectomy and radiotherapy without chemotherapy in frail patients with bladder cancer.
D'Andrea D; Soria F; Zehetmayer S; Stangl-Kremser J; Grubmüller B; Abufaraj M; Gust K; Kimura S; Babjuk M; Goldner GM; Shariat SF
Scand J Urol; 2020 Feb; 54(1):52-57. PubMed ID: 31975654
[No Abstract] [Full Text] [Related]
10. A nomogram predicting the cancer-specific mortality in patients eligible for radical cystectomy evaluating clinical data and neoadjuvant cisplatinum-based chemotherapy.
Di Trapani E; Sanchez-Salas R; Gandaglia G; Rocchini L; Moschini M; Lizee D; Carneiro A; Sivaraman A; Barret E; Rozet F; Galiano M; Bennamoun M; Colombo R; Suardi N; Briganti A; Montorsi F; Cathelineau X
World J Urol; 2016 Feb; 34(2):207-13. PubMed ID: 26198750
[TBL] [Abstract][Full Text] [Related]
11. Survival After Partial Cystectomy for Variant Histology Bladder Cancer Compared With Urothelial Carcinoma: A Population-based Study.
Luzzago S; Palumbo C; Rosiello G; Knipper S; Pecoraro A; Deuker M; Mistretta FA; Tian Z; Musi G; Montanari E; Shariat SF; Saad F; Briganti A; de Cobelli O; Karakiewicz PI
Clin Genitourin Cancer; 2020 Apr; 18(2):117-128.e5. PubMed ID: 32035800
[TBL] [Abstract][Full Text] [Related]
12. The effect of radical cystectomy on survival in patients with metastatic urothelial carcinoma of the urinary bladder.
Luzzago S; Palumbo C; Rosiello G; Pecoraro A; Deuker M; Tian Z; Shariat SF; Saad F; de Cobelli O; Karakiewicz PI
J Surg Oncol; 2019 Dec; 120(7):1266-1275. PubMed ID: 31562831
[TBL] [Abstract][Full Text] [Related]
13. More Extensive Lymph Node Dissection Improves Survival Benefit of Radical Cystectomy in Metastatic Urothelial Carcinoma of the Bladder.
Mazzone E; Preisser F; Nazzani S; Tian Z; Fossati N; Gandaglia G; Gallina A; Soulieres D; Tilki D; Montorsi F; Shariat SF; Saad F; Briganti A; Karakiewicz PI
Clin Genitourin Cancer; 2019 Apr; 17(2):105-113.e2. PubMed ID: 30527745
[TBL] [Abstract][Full Text] [Related]
14. Favourable outcomes of patients with clinical stage T3N0M0 bladder cancer treated with induction low-dose chemo-radiotherapy plus partial or radical cystectomy vs immediate radical cystectomy: a single-institutional retrospective comparative study.
Koga F; Kihara K; Fujii Y; Yoshida S; Saito K; Masuda H; Kageyama Y; Kawakami S
BJU Int; 2009 Jul; 104(2):189-94. PubMed ID: 19154452
[TBL] [Abstract][Full Text] [Related]
15. Pathological downstaging and survival after induction chemotherapy and radical cystectomy for clinically node-positive bladder cancer-Results of a nationwide population-based study.
Hermans TJ; Fransen van de Putte EE; Horenblas S; Meijer RP; Boormans JL; Aben KK; van der Heijden MS; de Wit R; Beerepoot LV; Verhoeven RH; van Rhijn BW
Eur J Cancer; 2016 Dec; 69():1-8. PubMed ID: 27814469
[TBL] [Abstract][Full Text] [Related]
16. Adenocarcinoma versus urothelial carcinoma of the urinary bladder: comparison between pathologic stage at radical cystectomy and cancer-specific mortality.
Lughezzani G; Sun M; Jeldres C; Alasker A; Budäus L; Shariat SF; Latour M; Widmer H; Duclos A; Jolivet-Tremblay M; Montorsi F; Perrotte P; Karakiewicz PI
Urology; 2010 Feb; 75(2):376-81. PubMed ID: 20022091
[TBL] [Abstract][Full Text] [Related]
17. How cancer-specific mortality changes over time after radical cystectomy: Conditional survival of patients with nonmetastatic urothelial carcinoma of the urinary bladder.
Palumbo C; Mistretta FA; Knipper S; Pecoraro A; Tian Z; Shariat SF; Saad F; Simeone C; Briganti A; Antonelli A; Karakiewicz PI
Urol Oncol; 2019 Dec; 37(12):893-899. PubMed ID: 31296422
[TBL] [Abstract][Full Text] [Related]
18. Oncologic Outcomes for Patients with Residual Cancer at Cystectomy Following Neoadjuvant Chemotherapy: A Pathologic Stage-matched Analysis.
Bhindi B; Frank I; Mason RJ; Tarrell RF; Thapa P; Cheville JC; Costello BA; Pagliaro LC; Karnes RJ; Thompson RH; Tollefson MK; Boorjian SA
Eur Urol; 2017 Nov; 72(5):660-664. PubMed ID: 28545841
[TBL] [Abstract][Full Text] [Related]
19. Persistent muscle-invasive bladder cancer after neoadjuvant chemotherapy: an analysis of Surveillance, Epidemiology and End Results-Medicare data.
Lane G; Risk M; Fan Y; Krishna S; Konety B
BJU Int; 2019 May; 123(5):818-825. PubMed ID: 30126053
[TBL] [Abstract][Full Text] [Related]
20. Survival after radical cystectomy of non-bilharzial squamous cell carcinoma vs urothelial carcinoma: a competing-risks analysis.
Abdollah F; Sun M; Jeldres C; Schmitges J; Thuret R; Djahangirian O; Tian Z; Shariat SF; Perrotte P; Montorsi F; Karakiewicz PI
BJU Int; 2012 Feb; 109(4):564-9. PubMed ID: 21810161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]